Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm
Identifieur interne : 000D18 ( Main/Exploration ); précédent : 000D17; suivant : 000D19Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm
Auteurs : Kevin B. Walsh [États-Unis] ; John R. Teijaro [États-Unis] ; Hugh Rosen [États-Unis] ; Michael B. A. Oldstone [États-Unis]Source :
- Immunologic Research [ 0257-277X ] ; 2011-10-01.
English descriptors
- KwdEn :
Abstract
Abstract: Initial and early tissue injury associated with severe influenza virus infection is the result of both virus-mediated lysis of infected pulmonary cells coupled with an exuberant immune response generated against the virus. The excessive host immune response associated with influenza virus infection has been termed “cytokine storm.” Therapies that target virus replication are available; however, the selective pressure by such antiviral drugs on the virus often results in mutation and the escape of virus progeny now resistant to the antiviral regimen, thereby rendering such treatments ineffective. This event highlights the necessity for developing novel methods to combat morbidity and mortality caused by influenza virus infection. One potential method is restricting the host’s immune response. However, prior treatment regimens employing drugs like corticosteroids that globally suppress the host’s immune response were found unsatisfactory in large part because they disrupted the host’s ability to control virus replication. Here, we discuss a novel therapy that utilizes sphingosine-1-phosphate (S1P) receptor signaling that has the ability to significantly limit immunopathologic injury caused by the host’s innate and adaptive immune response, thereby significantly aborting morbidity and mortality associated with influenza virus infection. Moreover, S1P analog therapy allows for sufficient anti-influenza T cell and antibody formation to control infection. We review the anti-inflammatory effects of S1P signaling pathways and how modulation of these pathways during influenza virus infection restricts immunopathology. Finally, we discuss that combinatorial administration of S1P simultaneously with a current antiviral enhances the treatment efficacy for virulent influenza virus infections above that of either drug treatment alone. Interestingly, the scope of S1P receptor therapy reported here is likely to extend beyond influenza virus infection and could prove useful for the treatment of multiple maladies like other viral infections and autoimmune diseases where the host’s inflammatory response is a major component in the disease process.
Url:
DOI: 10.1007/s12026-011-8240-z
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001494
- to stream Istex, to step Curation: 001494
- to stream Istex, to step Checkpoint: 000139
- to stream Main, to step Merge: 000D23
- to stream Main, to step Curation: 000D18
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm</title>
<author><name sortKey="Walsh, Kevin B" sort="Walsh, Kevin B" uniqKey="Walsh K" first="Kevin B." last="Walsh">Kevin B. Walsh</name>
</author>
<author><name sortKey="Teijaro, John R" sort="Teijaro, John R" uniqKey="Teijaro J" first="John R." last="Teijaro">John R. Teijaro</name>
</author>
<author><name sortKey="Rosen, Hugh" sort="Rosen, Hugh" uniqKey="Rosen H" first="Hugh" last="Rosen">Hugh Rosen</name>
</author>
<author><name sortKey="Oldstone, Michael B A" sort="Oldstone, Michael B A" uniqKey="Oldstone M" first="Michael B. A." last="Oldstone">Michael B. A. Oldstone</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3B37C15F55E839726447E3DA8EB8E7C214BC5D4A</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1007/s12026-011-8240-z</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-1CG33QWS-5/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001494</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001494</idno>
<idno type="wicri:Area/Istex/Curation">001494</idno>
<idno type="wicri:Area/Istex/Checkpoint">000139</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000139</idno>
<idno type="wicri:doubleKey">0257-277X:2011:Walsh K:quelling:the:storm</idno>
<idno type="wicri:Area/Main/Merge">000D23</idno>
<idno type="wicri:Area/Main/Curation">000D18</idno>
<idno type="wicri:Area/Main/Exploration">000D18</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm</title>
<author><name sortKey="Walsh, Kevin B" sort="Walsh, Kevin B" uniqKey="Walsh K" first="Kevin B." last="Walsh">Kevin B. Walsh</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Immunology and Microbial Science, The Scripps Research Institute, IMM-6, 10550 North Torrey Pines Rd, 92037, La Jolla, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Teijaro, John R" sort="Teijaro, John R" uniqKey="Teijaro J" first="John R." last="Teijaro">John R. Teijaro</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Immunology and Microbial Science, The Scripps Research Institute, IMM-6, 10550 North Torrey Pines Rd, 92037, La Jolla, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rosen, Hugh" sort="Rosen, Hugh" uniqKey="Rosen H" first="Hugh" last="Rosen">Hugh Rosen</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemical Physiology, The Scripps Research Institute, MEM-L55, 10550 North Torrey Pines Rd, 92037, La Jolla, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Oldstone, Michael B A" sort="Oldstone, Michael B A" uniqKey="Oldstone M" first="Michael B. A." last="Oldstone">Michael B. A. Oldstone</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Immunology and Microbial Science, The Scripps Research Institute, IMM-6, 10550 North Torrey Pines Rd, 92037, La Jolla, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Immunologic Research</title>
<title level="j" type="abbrev">Immunol Res</title>
<idno type="ISSN">0257-277X</idno>
<idno type="eISSN">1559-0755</idno>
<imprint><publisher>Humana Press Inc</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2011-10-01">2011-10-01</date>
<biblScope unit="volume">51</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="15">15</biblScope>
<biblScope unit="page" to="25">25</biblScope>
</imprint>
<idno type="ISSN">0257-277X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0257-277X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adaptive immunity</term>
<term>Cytokine storm</term>
<term>Dendritic cells</term>
<term>Influenza virus</term>
<term>Inmmunopathology</term>
<term>Innate immunity</term>
<term>Sphingosine analogs</term>
<term>Sphingosine-1-phosphate</term>
<term>T cells</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: Initial and early tissue injury associated with severe influenza virus infection is the result of both virus-mediated lysis of infected pulmonary cells coupled with an exuberant immune response generated against the virus. The excessive host immune response associated with influenza virus infection has been termed “cytokine storm.” Therapies that target virus replication are available; however, the selective pressure by such antiviral drugs on the virus often results in mutation and the escape of virus progeny now resistant to the antiviral regimen, thereby rendering such treatments ineffective. This event highlights the necessity for developing novel methods to combat morbidity and mortality caused by influenza virus infection. One potential method is restricting the host’s immune response. However, prior treatment regimens employing drugs like corticosteroids that globally suppress the host’s immune response were found unsatisfactory in large part because they disrupted the host’s ability to control virus replication. Here, we discuss a novel therapy that utilizes sphingosine-1-phosphate (S1P) receptor signaling that has the ability to significantly limit immunopathologic injury caused by the host’s innate and adaptive immune response, thereby significantly aborting morbidity and mortality associated with influenza virus infection. Moreover, S1P analog therapy allows for sufficient anti-influenza T cell and antibody formation to control infection. We review the anti-inflammatory effects of S1P signaling pathways and how modulation of these pathways during influenza virus infection restricts immunopathology. Finally, we discuss that combinatorial administration of S1P simultaneously with a current antiviral enhances the treatment efficacy for virulent influenza virus infections above that of either drug treatment alone. Interestingly, the scope of S1P receptor therapy reported here is likely to extend beyond influenza virus infection and could prove useful for the treatment of multiple maladies like other viral infections and autoimmune diseases where the host’s inflammatory response is a major component in the disease process.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="Walsh, Kevin B" sort="Walsh, Kevin B" uniqKey="Walsh K" first="Kevin B." last="Walsh">Kevin B. Walsh</name>
</region>
<name sortKey="Oldstone, Michael B A" sort="Oldstone, Michael B A" uniqKey="Oldstone M" first="Michael B. A." last="Oldstone">Michael B. A. Oldstone</name>
<name sortKey="Oldstone, Michael B A" sort="Oldstone, Michael B A" uniqKey="Oldstone M" first="Michael B. A." last="Oldstone">Michael B. A. Oldstone</name>
<name sortKey="Rosen, Hugh" sort="Rosen, Hugh" uniqKey="Rosen H" first="Hugh" last="Rosen">Hugh Rosen</name>
<name sortKey="Rosen, Hugh" sort="Rosen, Hugh" uniqKey="Rosen H" first="Hugh" last="Rosen">Hugh Rosen</name>
<name sortKey="Teijaro, John R" sort="Teijaro, John R" uniqKey="Teijaro J" first="John R." last="Teijaro">John R. Teijaro</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D18 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D18 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:3B37C15F55E839726447E3DA8EB8E7C214BC5D4A |texte= Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm }}
This area was generated with Dilib version V0.6.33. |